28 research outputs found
Additional file 2: of BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma
Supplementary Tables. (PDF 133 kb
Additional file 1: of TMEM106B haplotypes have distinct gene expression patterns in aged brain
Table S1. Tissue samples available and selected for inclusion in this study. Table S2. DEGS in TCX. Positive fold change represents higher gene expression in SS than TT. Negative fold change represents lower gene expression in SS than TT. Table S3. DEGS in CER. Positive fold change represents higher gene expression in SS than TT. Negative fold change represents lower gene expression in SS than TT. Table S4. Overlapping genes between TCX and CER based on top 500 genes with |FC| ≥ 1.2 ranked by unadjusted p value. Table S5. Enrichment of modules for their respective DEG signatures. Table S6. Significant modules identified in the TCX and CER matched cases. Table S7. Significant modules identified in separate disease groups in TCX and CER. Table S8. Significant modules identified in the TCX and CER controls. (DOCX 54 kb
Additional file 6: Figure S4. of The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831
Kaplan-Meier plots of distant recurrence by treatment arm for patients who are HR positive by local IHC, by quartile of HER2 expression by RT-PCR. (PDF 263 kb
Additional file 2: of Identification of missing variants by combining multiple analytic pipelines
Table S2. The composition of Tier 1, 2 and 3 variants in BWA-unique, Novo-unique and shared variants. (DOCX 13 kb
Additional file 4: of Identification of missing variants by combining multiple analytic pipelines
Table S4. The genomic location and GC content of multi-unique, single-unique and shared variants. (DOCX 14 kb
Additional file 1: of Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples
Figure S1-S17. Genome U plots of all the additional cases. Figure S18 Heat map of the EGFR and ERBB3 expression log2 expression by RNAseq. Dark red indicates low expression where yellow indicates high expression. Table S1 BRISQ summary of tumor specimens. (PPTX 3536 kb
Additional file 3: of Identification of missing variants by combining multiple analytic pipelines
Table S3. The percentage of known and novel variants in BWA-unique, Novo-unique and shared variants. (DOCX 13 kb
Additional file 1: of Identification of missing variants by combining multiple analytic pipelines
Table S1. The genomic location and GC content of BWA-unique, Novo-unique and shared variants. (DOCX 14 kb
Additional file 7: of Identification of missing variants by combining multiple analytic pipelines
Table S7. The full list of variants identified in APP, PSEN1 and PSEN2 by each workflow. (XLSX 14 kb
Additional file 5: of Identification of missing variants by combining multiple analytic pipelines
Table S5. The composition of Tier 1, 2 and 3 variants in multi-unique, single-unique and shared variants. (DOCX 14 kb